Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluoride concentrations in saliva and approximal fluid after different modes of fluoride administration
2005-000829-32Phase 2Active
- Sponsor
- Folktandvården
- Start
- Mar 2005
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules, Inorganic Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of triamcinolone and fluoride in carious lesion, sponsored by Folktandvården. Primary endpoints: Fluoride concentration in whole saliva, Fluoride concentration in approximal interdental fluid and 3 more. Started Mar 2005; status: active.
02
Drugs
triamcinolonefluoride
03
Conditions
carious lesion
Beyond the preview
Go deeper on 2005-000829-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-000829-32.